Molecules/SACITUZUMAB GOVITECAN

SACITUZUMAB GOVITECAN

Molecular Identity

Antibody drug conjugateApprovedFirst approved 2020

Mechanism of action: Tumor-associated calcium signal transducer 2 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

HRS7-SN38HRS7SN38HRS7-SN38-ANTIBODY-DRUG-CONJUGATEIMMU-132SACITUZUMAB GOVITECANSACITUZUMAB GOVITECAN HZIYSACITUZUMAB GOVITECAN-HZIYTrodelvy

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SACITUZUMAB GOVITECAN

Loading drug network...